EXOZYMES INC.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Other Information
Tyler Korman previously serving as the Vice President of Research and Development has been promoted to Chief Science Officer. The promotion was approved by the Board of Directors on November 10, 2025. Also on November 10, 2025, in connection with his promotion, the Compensation Committee and the Board increased Mr. Korman’s annual base salary to $250,000, effective November 15, 2025
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.